InMed Pharmaceuticals (QX) Stock Price - IMLFF

0.0008 (0.55%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
InMed Pharmaceuticals Inc (QX) IMLFF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0008 0.55% 0.1458 0.1379 0.14875 0.14 0.145 12:56:14
Bid Price Ask Price Spread Spread % News
0.1383 0.1458 0.0075 5.14% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
35 61,042 $ 0.140172 $ 8,556 329,811 0.1084 - 0.4146
Last Trade Time Type Quantity Stock Price Currency
12:56:14 300 $ 0.1458 USD

InMed Pharmaceuticals (QX) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 25.12M 172.28M $ -8.52M - - 135.52M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.74M $ - 0.00% - -

more financials information »

InMed Pharmaceuticals (QX) News

Loading Messages....

Latest IMLFF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IMLFF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.13080.15610.13080.1468971227,7870.01511.47%
1 Month0.180.180.10840.1451405388,563-0.0342-19.0%
3 Months0.18070.3220.10840.2058788343,237-0.0349-19.31%
6 Months0.19390.3220.10840.2008434286,565-0.0481-24.81%
1 Year0.3930.41460.10840.239026293,845-0.2472-62.9%
3 Years0.5931.950.10840.6452897594,280-0.4472-75.41%
5 Years0.2121.950.050.5689879452,131-0.0662-31.23%

InMed Pharmaceuticals (QX) Description

InMed Pharmaceuticals is a biopharmaceutical company developing a proprietary biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids, as well as a pipeline of cannabinoid-based medications that target diseases with high unmet medical needs. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines. For more information, visit

Your Recent History
InMed Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.